FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...

Last week, Adagio Therapeutics raised $80 million in a series B financing to speed its COVID-19 antibody into development. This week, it provided some details about how its approach differs from the ...

Blood collected from survivors of COVID-19 has been used to identify antibodies against the disease, which have been turned into experimental drugs to fight it. But it’s not an easy process. So back ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Tuesday, May 5, 2020 file photo, a health worker draws blood from a patient for a COVID-19 coronavirus antibody ...

A number of commercially available COVID-19 antibody tests, which look at a patient’s blood for signs of past infection, did not pass Mayo Clinic quality screening or meet their expectations for use, ...

COLUMBIA - Columbia-based laboratory Helix Specialty Diagnostics is offering COVID-19 antibody tests to local businesses beginning Monday. The tests are mainly intended for employers to determine if ...

MOSCOW -- When Russians talk about the coronavirus over dinner or in hair salons, the conversation often turns to "antitela," the Russian word for antibodies -- the proteins produced by the body to ...

FRANKFURT, Dec 14 (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N), opens new tab and Regeneron (REGN.O), opens new tab lose most of their effectiveness ...

German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus. The ...